Ferric ammonium citrate
CAS 1185-57-5
Ferric ammonium citrate (CAS 1185-57-5) is a pharmaceutical compound with 0 bioactivity targets and 11 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Cross-Reference to Chemicals
Same-CAS substance identity is available in the industrial chemicals vertical.
Ferric ammonium citrate is linked to DTXSID9040477 in DSSTox identifiers.
View industrial chemical data →Drug Names / RxNorm
Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.
| Name | RxCUI | Type | Source |
|---|---|---|---|
| FERRIC AMMONIUM CITRATE | 24897 | SU | MTHSPL |
| ferric ammonium citrate | 24897 | SU | MTHSPL |
| ferric ammonium citrate | 24897 | IN | RXNORM |
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Ferric ammonium citrate used for in pharmaceutical contexts?
Ferric ammonium citrate (CAS 1185-57-5) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Ferric ammonium citrate?
Ferric ammonium citrate has 11 DrugCentral/FAERS adverse event associations. Rendered reaction terms include Amino acid level abnormal, Blood pressure increased, Dyspnoea, Heart rate increased, Loss of consciousness. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Ferric ammonium citrate also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for Ferric Ammonium Citrate with EU status "permitted".
What clinical phase is Ferric ammonium citrate in?
No phase 1-4 clinical development badge is rendered for Ferric ammonium citrate because the matched compound identifier rows do not contain a max-phase value.